X0306
4
2015-05-14
1
0001113148
INFINITY PHARMACEUTICALS, INC.
INFI
0001375124
Perkins Adelene Q
C/O INFINITY PHARMACEUTICALS, INC.
784 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
1
1
0
0
President & CEO
Common Stock
2015-05-14
4
S
0
10000
12.18
D
374432
D
Common Stock
6832.9855
I
By 401(k)
The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 26, 2014.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.01 to $12.50, inclusive. The reporting person undertakes to provide to Infinity Pharmaceuticals, Inc., any security holder of Infinity Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2.
Ex. 24: Limited Power of Attorney
/s/ Seth A. Tasker as attorney-in-fact for Adelene Q. Perkins
2015-05-15